R. Saso

发表

Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)

S. Singhal, J. Mehta, D. Tait, 1999, Bone Marrow Transplantation.

Sequential development of myelodysplasia and acute myeloid leukemia but with no karyotypic evolution after autografting in a patient with Philadelphia positive acute lymphoblastic leukemia.

S. Singhal, J. Mehta, R. Powles, 1997, Leukemia & lymphoma.

Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin

G. Morgan, J. Tredger, F. Davies, 2011, Clinical transplantation.

Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants.

S. Singhal, J. Mehta, B. Sirohi, 2000, Blood.

Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study

G. Morgan, B. Sirohi, G. Cook, 2007, Bone Marrow Transplantation.

The impact of extramedullary disease at presentation on the outcome of myeloma

G. Morgan, F. Davies, B. Shaw, 2009, Leukemia & lymphoma.

Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis

G. Morgan, F. Davies, B. Shaw, 2011, Hematology.

Lenolidamide (Revlimid), in Combination with Cyclophosphamide and Dexamethasone (CRD) Is an Effective Regimen for Heavily Pre-Treated Myeloma Patients.

G. Morgan, M. Jenner, F. Davies, 2006 .

Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft

S. Singhal, J. Mehta, B. Sirohi, 2005, Hematology.

Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype

Robin L. Jones, G. Morgan, S. Singhal, 2008, Leukemia & lymphoma.

Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?

S. Singhal, J. Mehta, B. Sirohi, 2003, Bone Marrow Transplantation.

Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an ‘operational cure’?

S. Singhal, J. Mehta, B. Sirohi, 2002, Bone Marrow Transplantation.

Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation

S. Singhal, J. Mehta, B. Sirohi, 2000, Bone Marrow Transplantation.

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma

J. Mehta, T. Powles, S. Ashley, 2000, British Journal of Cancer.

Melphalan/TBI is not more carcinogenic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years

S. Singhal, J. Mehta, D. Tait, 2000, Bone Marrow Transplantation.

The combination of cyclophosphamide, velcade and dexamethasone induces high response rates with comparable toxicity to velcade alone and velcade plus dexamethasone.

G. Morgan, M. Jenner, F. Davies, 2007, Haematologica.

The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients

G. Morgan, S. Singhal, J. Mehta, 2008, Bone Marrow Transplantation.

The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy.

S. Singhal, J. Mehta, T. Min, 1999, Leukemia & lymphoma.

Impact of previous high-dose therapy on outcome after allografting for multiple myeloma

S. Singhal, J. Mehta, D. Tait, 1999, Bone Marrow Transplantation.

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

S. Singhal, J. Mehta, D. Tait, 2000, Bone Marrow Transplantation.

Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse.

S. Singhal, J. Mehta, R. Powles, 1999, Leukemia & lymphoma.

Secondary leukaemia characterised by monosomy 7 occurring post-autologous stem cell transplantation for AML

J. Swansbury, T. Min, R. Powles, 1998, Bone Marrow Transplantation.

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma

M. Kaiser, A. Sud, K. Boyd, 2021, The Lancet Haematology.

Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma – a phase I/II feasibility and tolerance study of 17 patients

S. Singhal, J. Mehta, N. Raje, 2000, Bone Marrow Transplantation.

Red cell fragmentation (schistocytosis) after bone marrow transplantation

S. Singhal, J. Mehta, J. Treleaven, 1998, Bone Marrow Transplantation.

Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease

S. Singhal, J. Mehta, B. Sirohi, 2003, Bone Marrow Transplantation.

Acute myeloid leukaemia Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?

S. Singhal, J. Mehta, D. Tait, 2002 .

Does donor–recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?

S. Singhal, J. Mehta, D. Tait, 2002, Bone Marrow Transplantation.

Bone marrow transplants for paroxysmal nocturnal haemoglobinuria

L. Luzzatto, J. Szer, M. Horowitz, 1999, British journal of haematology.

Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.

S. Singhal, J. Mehta, R. Powles, 1996, Bone marrow transplantation.

Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia

C. Delord, J. Treleaven, R. Powles, 1999, Bone Marrow Transplantation.

The novel monoclonal antibody By114 helps detect the early emergence of a paroxysmal nocturnal hemoglobinuria clone in aplastic anemia.

K. Pulford, J. Tooze, E. Gordon-Smith, 1995, Experimental hematology.

Deficiency of glycosylphosphatidyl inositol‐anchored proteins in patients with aplastic anaemia does not affect response to immunosuppressive therapy

J. Tooze, E. Gordon-Smith, J. Marsh, 1998, British journal of haematology.

The implication of compromised renal function at presentation in myeloma

S. Singhal, J. Mehta, N. Raje, 2001, Medical oncology.

Long‐term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high‐dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments

G. Morgan, C. Dearden, F. Davies, 2005, British journal of haematology.

High‐grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis

D. Catovsky, A. Wotherspoon, E. Matutes, 2008, British journal of haematology.

Glomerular filtration rate prior to high-dose melphalan 200 mg/m2as a surrogate marker of outcome in patients with myeloma

S. Singhal, J. Mehta, B. Sirohi, 2001, British Journal of Cancer.

Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system

S. Singhal, J. Mehta, N. Raje, 1999, British journal of haematology.

An elective single autograft with high-dose melphalan: single-center study of 451 patients

S. Singhal, J. Mehta, B. Sirohi, 2005, Bone Marrow Transplantation.

The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide – vincristine – doxorubicin – methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis

G. Morgan, M. Jenner, F. Davies, 2006, Leukemia & lymphoma.

A mathematical model of cell equilibrium and joint cell formation in multiple myeloma.

M. Koenders, R. Saso, 2016, Journal of theoretical biology.

Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria

S. Singhal, J. Mehta, B. Sirohi, 2001, Bone Marrow Transplantation.

Ocular and cerebral aspergillosis in a non-neutropenic patient following alemtuzumab and methyl prednisolone treatment for chronic lymphocytic leukaemia

C. Dearden, M. Stanford, P. Anoop, 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemia.

S. Singhal, J. Mehta, P. Glynne, 1996, Seminars in hematology.

Absence of N‐RAS point mutations in peripheral blood cells of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinurea

J. Tooze, E. Gordon-Smith, T. Rutherford, 1995, British journal of haematology.

Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma

G. Morgan, F. Davies, K. Boyd, 2012, British journal of haematology.

The Combination of Cyclophosphamide, Velcade and Dexamethasone (CVD) Induces High Response Rates with Minimal Toxicity Compared to Velcade Alone (V) and Velcade Plus Dexamethasone (VD).

G. Morgan, M. Jenner, F. Davies, 2006 .

Peripheral blood stem cells Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'?

S. Singhal, J. Treleaven, S. Goyal, 2002 .